Aims Randomized data on the efficacy/safety of cardiac resynchronization therapy with vs.
without defibrillator (CRT-D,-P) in heart failure with reduced ejection fraction (HFrEF) are …

BACKGROUND: Cardiac resynchronization therapy (CRT) reduces mortality in selected
patients with heart failure. However, this result may not be entirely related to the beneficial …

Clinical guidelines are systematically developed statements and recommendations
regarding clinical decision making to help practitioners and patients to make the most …

Cost Effectiveness of MADIT‐CRT. Background: The Multicenter Automatic Defibrillator
Implantation Trial‐Cardiac Resynchronization Therapy (MADIT‐CRT) trial demonstrated that …

Among 1,138 patients in our congestive heart failure care management database, 37 (3.2%)
met guideline criteria for cardiac resynchronization therapy. Advancing age was a predictor …

Background: Cardiac resynchronization therapy (CRT) improves symptoms, left ventricular
ejection fraction (LVEF) and survival in patients with heart failure and wide QRS, however …

Aims We hypothesized that the relationship between LVEF and the risk of life‐threatening
ventricular tachyarrhythmias (VTAs) may modify the effect of a CRT device with a defibrillator …

Objectives: We evaluated the ability of delayed enhancement magnetic resonance imaging
(DE-MRI) to predict clinical response to cardiac resynchronization therapy (CRT) …

Background: Cardiac resynchronisation therapy (CRT) improves outcomes in selected
patients with heart failure and left ventricular dysfunction. One mechanism of benefit is …

Objectives: This study was designed to investigate whether selected baseline variables and
early response markers predict the effects of cardiac resynchronization therapy (CRT) on …